SEP 10, 2026 · JOURNAL ARTICLE
Shikonin as a Parkin-dependent hypoxia-selective agent against triple-negative breast cancer identified by machine learning
BMC Cancer
In vitro mechanistic study using cell lines and machine learning on retrospective data; no clinical trial, no animal efficacy model, and no direct evidence of human benefit. Raises questions about shikonin's potential but does not answer them.
Reported
Machine learning training cohort…1,092